Cargando…
A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
Sarcopenia is highly prevalent in patients with advanced chronic kidney disease (CKD), yet a reliable serum index has not been established. The product of serum creatinine and the estimated glomerular filtration rate based on cystatin C (Cr×eGFRcys) was recently proposed as a sarcopenia index (SI),...
Autores principales: | Lin, Yu-Li, Wang, Chih-Hsien, Chang, I-Chen, Hsu, Bang-Gee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914226/ https://www.ncbi.nlm.nih.gov/pubmed/35284461 http://dx.doi.org/10.3389/fnut.2022.828880 |
Ejemplares similares
-
Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022) -
Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
por: Lin, Yu-Li, et al.
Publicado: (2021) -
Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022) -
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer
por: Tang, Tianjiao, et al.
Publicado: (2022) -
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)